See more : BioPharma Credit PLC (BPCR.L) Income Statement Analysis – Financial Results
Complete financial analysis of Asep Medical Holdings Inc (ASEP.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Asep Medical Holdings Inc, a leading company in the Biotechnology industry within the Healthcare sector.
- PROEN Corp Public Company Limited (PROEN.BK) Income Statement Analysis – Financial Results
- Osisko Development Corp. (ODV.V) Income Statement Analysis – Financial Results
- Skåne-möllan AB (publ) (SKMO.ST) Income Statement Analysis – Financial Results
- Haier Smart Home Co., Ltd. (6690.HK) Income Statement Analysis – Financial Results
- Huang Hsiang Construction Corporation (2545.TW) Income Statement Analysis – Financial Results
Asep Medical Holdings Inc (ASEP.CN)
About Asep Medical Holdings Inc
Asep Medical Holdings Inc., through its subsidiary, ASEP Medical Inc. focuses on developing an early diagnostic tool for Sepsis and peptide therapeutic treatments for multiple applications. The company was formerly known as Trenchant Life Sciences Investment Corp. and changed its name to Asep Medical Holdings Inc. Asep Medical Holdings Inc. was incorporated in 2020 and is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 21.14K | 0.00 | 0.00 | 0.00 | 61.17K |
| Cost of Revenue | 134.88K | 155.40K | 177.18K | 26.45K | 55.01K |
| Gross Profit | -113.74K | -155.40K | -177.18K | -26.45K | 6.16K |
| Gross Profit Ratio | -538.03% | 0.00% | 0.00% | 0.00% | 10.07% |
| Research & Development | 678.54K | 615.04K | 73.60K | 0.00 | 0.00 |
| General & Administrative | 4.23M | 2.54M | 1.73M | 1.65K | 6.51K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 4.23M | 2.54M | 1.73M | 1.65K | 6.51K |
| Other Expenses | 2.70M | 2.28M | 177.18K | 0.00 | 0.00 |
| Operating Expenses | 7.74M | 5.44M | 1.98M | 1.65K | 6.51K |
| Cost & Expenses | 7.74M | 5.44M | 1.98M | 28.10K | 61.53K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 270.00 | 814.00 | 102.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 1.29M | 1.28M | 177.18K | 28.10K | 353.00 |
| EBITDA | -8.14M | -4.56M | -2.06M | 0.00 | 0.00 |
| EBITDA Ratio | -38,486.19% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -7.72M | -5.44M | -1.98M | -28.10K | -353.00 |
| Operating Income Ratio | -36,524.42% | 0.00% | 0.00% | 0.00% | -0.58% |
| Total Other Income/Expenses | -1.71M | -403.73K | -289.55K | 0.00 | 0.00 |
| Income Before Tax | -9.43M | -5.85M | -2.34M | -28.10K | -353.00 |
| Income Before Tax Ratio | -44,609.81% | 0.00% | 0.00% | 0.00% | -0.58% |
| Income Tax Expense | 0.00 | -89.10K | -41.48K | 0.00 | 0.00 |
| Net Income | -8.23M | -5.76M | -2.30M | -28.10K | -353.00 |
| Net Income Ratio | -38,918.30% | 0.00% | 0.00% | 0.00% | -0.58% |
| EPS | -0.13 | -0.10 | -0.04 | 0.00 | 0.00 |
| EPS Diluted | -0.13 | -0.10 | -0.04 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 62.24M | 56.20M | 56.13M | 14.91M | 14.91M |
| Weighted Avg Shares Out (Dil) | 62.24M | 56.20M | 56.13M | 14.91M | 14.91M |
Source: https://incomestatements.info
Category: Stock Reports